5 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... infection Episode #Pharmacology ... #Management #CDiff ... IDSA2017 #Adjunct #Antibiotics
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile ... Class Pooled and ... #CDifficile #Infection ... #Pharmacology # ... #Clostridium #Table
Antibiotics for Anaerobic Bacteria 
 - Metronidazole (Flagyl™) 
 - Carbapenems 
 - β lactam +
Antibiotics for ... aspiration pna; and ... out of favor for C.diff ... Anaerobic #Bacteria #Pharmacology ... #Table #Susceptibility
Potential Treatment Agents for Treatment of the Primary Clostridium difficile infection Episode
Proven efficacy:
 • Vancomycin -
Primary Clostridium difficile ... × 10 days #CDiff ... treatment #management #pharmacology ... #idsa #table
IDSA Recommended Dosages of Antimicrobial Agents Administered by the Intraventricular Route
Amikacin - 5–50 mg
Amphotericin B -
IDSA Recommended ... Intraventricular #antibiotics ... #dosing #pharmacology ... ventriculitis #table ... #idsa